Clinical Trial Update: A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. [Phase 2]

View source ↗

Summary

Phase 2 trial update for THR-687 in diabetic macular edema was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• THR-687

Snippet

Sponsor: Oxurion | Conditions: Diabetes Mellitus, Diabetic Retinopathy | Phase 2 | Status: TERMINATED | Results posted: 2023-08-18